データを補完しています。しばらくしてからページを更新すると最新の内容を表示できます
328-50-7O=C(O)CCC(=O)C(=O)OKPGXRSRHYNQIFN-UHFFFAOYSA-N2-oxoglutaric acid is an oxo dicarboxylic acid that consists of glutaric acid bearing an oxo substituent at position 2. It is an intermediate metabolite in Krebs cycle. It has a role as a fundamental metabolite. It is functionally related to a glutaric acid. It is a conjugate acid of a 2-oxoglutarate(1-).
328-50-7、34410-46-3DTXSID5033179CHEMBL1686CHEBI:30915541.5 mg/mL
soluble in water at >1000 g/l at 20�C and petrolatum at <100 g/kg at 20�C
(in ethanol)
Solid; [Merck Index] White to off-white solid; [Acros Organics MSDS]
Solid
white to pale yellow crystalline powder
124.43 Ų [M-H]- [CCS Type: DT; Method: stepped-field]
120.9 Ų [M-H]- [CCS Type: DT; Method: single field calibrated with ESI Low Concentration Tuning Mix (Agilent)]
安全情報は参考情報です。供給元の安全データシート(SDS)、適用法令、専門家による評価に代わるものではありません。
This chemical does not meet GHS hazard criteria for 0.4% (1 of 236) of reports.
Danger
H315 (40.3%): Causes skin irritation [Warning Skin corrosion/irritation]
P261, P264, P264+P265, P271, P280, P302+P352, P304+P340, P305+P354+P338, P317, P319, P321, P332+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 236 reports by companies from 12 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
Chemical: Pentanedioic acid, 2-oxo-
Status: Active Update: 28-10-2020 https://echa.europa.eu/registration-dossier/-/registered-dossier/21616
2-Oxoglutaric acid: Does not have an individual approval but may be used under an appropriate group standard
Causes convulsions in acute intraperitoneal studies of mice; Causes other liver changes and multiple enzyme effects in 20-week intermittent oral studies of rats; [RTECS] Safe when used as a flavoring agent in food; [JECFA] An eye irritant that may cause corneal injury; [Acros Organics MSDS]
The exact mechanisms of action for α-Ketoglutarate have not yet been elucidated. Some of α-Ketoglutarate’s actions include acting in the Krebs cycle as an intermediate, transamination reactions during the metabolism of amino acids, forming glutamic acid by combining with ammonia, and reducing nitrogen by combining with it as well. Concerning α-Ketoglutarate’s actions with ammonia, it is proposed that α-Ketoglutarate can help patients with propionic academia who have high levels of ammonia and low levels of glutamine/glutamate in their blood. Because endogenous glutamate/glutamine is produced from α-Ketoglutarate, propionic acidemia patients have impaired production of α-Ketoglutarate and supplementation of α-Ketoglutarate should improve the condition of these patients. Several other experimental studies have also shown that administration of α-Ketoglutarate in parenteral nutrition given to post-operative patients helped attenuate the decreased synthesis of muscle protein that is often seen after a surgery. This decreased muscle synthesis is speculated to be due to too low α-Ketoglutarate levels.
Flavouring Agent -> FLAVOURING_AGENT -> JECFA Functional Classes
121.1 Ų [M-H]-
Flavoring Agents -> JECFA Flavorings Index
Flavouring Agent -> FLAVOURING_AGENT -> JECFA Functional Classes
Flavouring Agent -> FLAVOURING_AGENT -> JECFA Functional Classes
Flavouring Agent -> FLAVOURING_AGENT -> JECFA Functional Classes
Cosmetics -> Deodorant